While the review claims to bridge preclinical models with clinical data, the abstract doesn't address how well animal model findings predict human ASD pathophysiology or treatment responses. This translation gap is crucial for clinical application of mTOR-targeted therapies. Gap type: open_question Source paper: mTOR signaling pathway as a pathophysiologic mechanism in preclinical models of autism spectrum disorder. (None, None, PMID:39481829)
Landscape Summary: How do findings from preclinical mTOR-related ASD models translate to clinical populations and therapeutic outcomes? is a 0.75 priority gap in translational-neuroscience. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How do findings from preclinical mTOR-related ASD models translate to clinical populations and therapeutic outcomes? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: